WeVote
Log In

Bill

Bill

HB 4402

KIDNEY TREATMENT DELEGATE ACT

104th Regular Session Introduced by Bob Rita

Illinois bill authorizing delegation of kidney treatment decision-making authority, likely expanding roles for non-physician healthcare providers in nephrology care management.

Referred to Rules Committee
0
WeVote Research Nonpartisan
Bill Summary · HB 4402

Legislative bill overview

HB 4402, the Kidney Treatment Delegate Act, has been introduced in the Illinois House but detailed legislative text is not yet publicly available at this early stage (first reading, January 2026). Based on the title, the bill likely addresses delegation of kidney treatment responsibilities, possibly involving medical decision-making authority, treatment protocols, or expanded scope of practice for certain healthcare providers in kidney disease management.

Why is this important

Kidney disease affects approximately 37 million Americans, with treatment decisions significantly impacting patient outcomes and quality of life. Clarifying or expanding who can make or delegate kidney treatment decisions could affect access to care, treatment quality, and healthcare costs—particularly relevant given Illinois's diverse patient population and varying access to nephrologists.

Potential points of contention

  • Scope of practice expansion: Healthcare provider unions and physician groups may dispute whether non-physician providers (nurses, physician assistants) should have expanded authority in kidney treatment decisions
  • Patient safety concerns: Medical organizations may raise questions about qualifications, oversight mechanisms, and liability if delegation occurs without adequate safeguards
  • Access vs. quality trade-off: Rural healthcare advocates may support broader delegation for access reasons, while specialists may argue it compromises treatment quality and specialized expertise

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.